A quiet change in North Dakota law gives pharmacists more flexibility—and creates new decisions pharmacy owners need to understand.
Most North Dakota pharmacy owners don't realize that as of the filing of SB2402 with the Secretary of State, their pharmacists now have legal authority to dispense a different drug than the one prescribed—without calling the doctor first.
This isn't a small procedural tweak. It changes how you stock inventory, train staff, manage liability, and handle customer interactions. Here's what actually changed and what it means for your business.
Under Section 4 of SB2402 (Page 8), pharmacists may now substitute a therapeutically equivalent drug for the one a prescriber ordered. "Therapeutically equivalent" means the substitute drug produces the same clinical effect, even if it's not chemically identical—typically a generic version or a different brand-name drug in the same class.
The key word is "may." Your pharmacist isn't required to substitute; they have the discretion to do so when it makes sense.
The law isn't a free pass. Three conditions must be met:
Prescriber notification: You must notify the prescriber within 24 hours of dispensing the substitute drug.
Patient consent: The patient must agree to receive the different medication.
Patient counseling: Your pharmacist must counsel the patient about the substitution.
These aren't optional steps. They're built into the legal authority, and skipping any of them exposes your pharmacy to liability.
Inventory and cost control: If a patient's prescribed brand-name drug is out of stock but you have a therapeutically equivalent generic in hand, you can dispense it immediately instead of sending the customer elsewhere or delaying their medication. This reduces lost sales and improves customer retention.
Workflow changes: Your team needs clear protocols for when substitution makes sense, how to document it, and how to complete the 24-hour prescriber notification. Without written procedures, you risk missed notifications or incomplete counseling records.
Staff training: Pharmacists and technicians need to understand which drugs are therapeutically equivalent, how to present substitution options to patients, and how to handle patient questions. Inconsistent communication can create confusion or erode trust.
Liability and documentation: Your pharmacy records must clearly show that patient consent was obtained, counseling occurred, and the prescriber was notified within 24 hours. If a problem arises later, documentation is your protection.
SB2402 became effective upon filing with the Secretary of State (Section 7, Page 9). This means the authority is already in place. If you haven't reviewed your policies and staff training since the bill's passage, now is the time.
Next step: Review your current dispensing procedures against these three legal requirements. If you'd like a free, business-specific guide to implementing compliant substitution practices, contact your pharmacy association or legal counsel.